Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
All of these stimulate GLP-1 when eaten
Similar mechanism to pregabalin with a longer track record
Our 2030 estimates contemplate global penetration into the addressable type 2 diabetes and obesity markets of only 8% and 2%, respectively (from about 3% and 0.2% in 2023). Uptake would likely be greater if these drugs could be consumed in oral form rather than injected, adds the report, An oral weight loss agent would likely be well-received in the primary care setting and could alleviate pressure on supply chains
Hsu AHC et al
US$ 28.38
US$ 21.52
US$ 28.15
US$ 22.14
US$ 26.47
